Literature DB >> 31924388

Evaluation of patient risk factors for infection with carbapenem-resistant Enterobacteriaceae.

Marko Predic1, John P Delano2, Elizabeth Tremblay2, Nicole Iovine3, Scott Brown2, Cindy Prins4.   

Abstract

BACKGROUND: To evaluate risk factors for infection or colonization with carbapenem-resistant Enterobacteriaceae (CRE) to develop an algorithm for targeted CRE screening.
METHODS: We conducted a case-control study of 50 CRE-positive cases and 100 CRE-negative controls to identify risk factors that were significant for CRE infection or colonization. The setting was at an acute care academic hospital. Patients who tested positive for CRE or other microbiological laboratory tests during the study period were included. We reviewed medical records of 50 patients who were CRE-positive and 100 matched controls who had a non-CRE culture at a similar anatomic site within the closest time period to the case's culture date. Risk factors were assessed using logistic regression with SAS 9.4, observing the 95% confidence interval (CI) to determine significance.
RESULTS: Significant risk factors for CRE infection or colonization included the use of fluoroquinolones (odds ratio [OR], 3.75; 95% CI, 1.35, 10.38) and cephalosporins (OR, 2.37; 95% CI, 1.17, 4.86). In addition, undergoing an invasive procedure with a scope device was also a significant risk factor for our participants (OR, 4.57; 95% CI, 1.31, 16.02). Significance of these risk factors varied within the community-acquired and hospital-acquired cases.
CONCLUSIONS: Our results suggest that exposure to certain antimicrobials and invasive procedures with a scope device (endoscopic retrograde cholangiopancreatography, duodenal endoscope) are risk factors for CRE. The findings of significant differences in antimicrobials received highlight the necessity to understand antimicrobial stewardship in the development of CRE colonization and infection. Along with antibiotics, inaccessibility to components within scope devices may be increasing the risk of CRE spread.
Copyright © 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRE; Carbapenems; Case control study; Epidemiology; MDRO

Mesh:

Substances:

Year:  2020        PMID: 31924388     DOI: 10.1016/j.ajic.2019.11.025

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  3 in total

1.  Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.

Authors:  Mei-Chun Lee; Hsun Chang; Fang-Ju Sun; Alice Ying-Jung Wu; Chien-Hung Lu; Chun-Ming Lee
Journal:  Am J Trop Med Hyg       Date:  2022-06-13       Impact factor: 3.707

2.  Acquisition and carriage of multidrug-resistant organisms in dogs and cats presented to small animal practices and clinics in Switzerland.

Authors:  Valentina Dazio; Aurélien Nigg; Janne S Schmidt; Michael Brilhante; Nico Mauri; Stephan P Kuster; Stefanie Gobeli Brawand; Gertraud Schüpbach-Regula; Barbara Willi; Andrea Endimiani; Vincent Perreten; Simone Schuller
Journal:  J Vet Intern Med       Date:  2021-02-01       Impact factor: 3.333

3.  Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.

Authors:  Rima Moghnieh; Dania Abdallah; Marwa Jadayel; Wael Zorkot; Hassan El Masri; Marie Joe Dib; Tasnim Omar; Loubna Sinno; Rawad Lakkis; Tamima Jisr
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.